Sangamo Therapeutics Announces Fourth Quarter and Full Year 2025 Earnings Call

Click here to view

Infectious Disease (HIV/AIDS)

Human hematopoietic stem/progenitor cells modified by zinc-finger nucleases targeted to CCR5 control HIV-1 in vivo.
August 24th, 2018
Engineering hematopoietic stem cells toward a functional cure of human immunodeficiency virus infection.
August 24th, 2018
Long-term multilineage engraftment of autologous genome-edited hematopoietic stem cells in nonhuman primates.
August 24th, 2018
Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV.
August 24th, 2018